Isotope labelled Dolutegravir SR Isomer is an isomeric derivative of Dolutegravir, a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has
Molecular Weight:
422.4
* VAT and and shipping costs not included. Errors and price changes excepted
